The first study of its kind has found cannabis to be beneficial in the treatment of female orgasm disorder.
PTSD symptoms significantly reduced three months after starting treatment with cannabis-based medicines.
More details of how France’s long-awaited medical cannabis generalisation will look have been published.
Early economic analysis suggests that at the right price point, cannabis-based medicines could offer a cost-effective alternative for chronic pain.
Cash has described CBD as a ‘gamechanger’ for athletes living with chronic pain.
It is the first randomised trial to examine how legal, commercially available cannabis impacts anxiety symptoms.
Exploring the cutaneous Endocannabinoid System and its potential applications in treating various dermatological conditions.
A notable reduction in crystal meth use was observed among those who used cannabis for craving management.
Greece was among the first in Europe to legalise medical cannabis in 2017.
Spain’s Ministry of Health has launched a public consultation on its proposals for a medical cannabis framework in the country.